The Senate this week passed two bills to help women at high risk for breast cancer, ensuring coverage for MRIs, ultrasounds and genetic testing with no out-of-pocket costs.
Breast cancer is the second-most common cancer in women in the United States after skin cancers, and early detection is the key to saving lives. The Senate approved the following bills:
Senate Bill 1225 eliminates out-of-pocket costs for breast MRI and ultrasound for women with high-risk conditions such as dense breast tissue, a family history of breast cancer, personal history of breast cancer, genetic predisposition or prior radiation therapy.
Senate Bill 1330 removes costs associated with genetic testing and counseling for Pennsylvanians with a family history of breast and ovarian cancers. Genetic testing for heredity cancers provides the opportunity for earlier screenings and preventive treatments and procedures.
At a news conference celebrating passage of the bills, PA Breast Cancer Coalition President Pat Halpin-Murphy said: “Senate Bill 1225 and Senate Bill 1330 will arm the women of Pennsylvania with the best tools possible to find breast cancer at its earliest, most treatable stage.”
Original source can be found here.
Alerts Sign-up